AUG 04, 2019 7:20 AM PDT

Understanding TP53's role in cancer

New research published in the journal Cell Reports sheds light on the role of the TP53 gene in preventing the spread of cancer. The TP53 gene codes tumor protein p53, a tumor suppressor that stops cells from dividing and proliferating too fast. Because of this important capability, many previous studies have looked into the role that TP53 plays in cancer; however, this study is the largest to date, incorporating over 10,000 cancer patients and 32 different kinds of cancer. The research was led by Dr. Larry Donehower, a professor of molecular virology and microbiology at the Baylor College of Medicine in Houston, TX.

Using data from The Cancer Genome Atlas (TCGA), the researchers Dr. Donehower and his colleagues were able to identify four genes that show overexpression in mutant TP53 tumors. They linked these four genes to a patient’s prognosis. Dr. Donehower explains:

"If you have a high expression of those four genes, you have a patient who's more likely to have a bad prognosis [...] Conversely, if that patient has a very low expression of those genes, (s)he's probably going to survive longer and have a good prognosis. It will give you a better picture of how (s)he'll fare than just knowing whether (s)he's mutant for TP53 or not.”

But that’s not the only finding from this study: the researchers also concluded that TP53 mutations are associated with genetic instability and occur more frequently in patients with a poorer outlook. They also determined that over 91% of cancers with TP53 mutations also exhibit the “loss of both functional TP53 alleles," or gene variants. These discoveries are significant to widening the scientific community’s understanding of TP53 and its role in cancer.

New research illuminates the role of TP53 in cancer. Photo: Pixabay

The distinction with this study, says Dr. Donehower, was its breadth. "Most studies on TP53focus on one cancer type. Looking at 32 different cancer types, you see that certain patterns hold up regardless of cancer type."

Co-author David Wheeler agrees, elaborating that their findings could help develop more treatments. "Since TP53 is one of the most important gatekeepers in cancer prevention, the better we understand this gene, the better able we will be to understand the basic biology of cancer. That will lead to better therapies."

Sources: Medical News Today, Cell Reports

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 10, 2021
Cancer
Advancements in nanotech pave the way for improved chemotherapy
MAY 10, 2021
Advancements in nanotech pave the way for improved chemotherapy
New research from Massachusetts General Hospital (MGH) reports on a development in improving the effectiveness of c ...
MAY 28, 2021
Genetics & Genomics
Some Biofilms Seem to Activate Cancer Genes
MAY 28, 2021
Some Biofilms Seem to Activate Cancer Genes
New research assessed bacterial and fungal biofilms, tenacious microbial communities that are tougher than small groups ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
JUN 09, 2021
Clinical & Molecular DX
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
JUN 09, 2021
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
Scientists have created a gene panel test to quickly and more precisely diagnose common forms of liposarcoma. This break ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUN 23, 2021
Cancer
Military universal health system boasts higher survival rates for colon cancer patients
JUN 23, 2021
Military universal health system boasts higher survival rates for colon cancer patients
New results published in the American Association for Cancer Research journal Cancer Epidemiology, Biomarkers & Prev ...
Loading Comments...